MESO:NASDAQ
Mesoblast Ltd
$14.27
arrow_upward
+1.21%(+0.17) 1D
$14.27
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 6, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MESO...
Open
$14.00
High
$14.31
Low
$13.82
Mkt. cap
1.98B
Avg. vol.
286.84K
Volume
192.84K
52-wk high
$21.50
52-wk low
$11.89
EPS
-$0.44
Beta
2.21
Shares outstanding
130.13M
No. of employees
108
Open
$14.00
High
$14.31
Low
$13.82
Mkt. cap
1.98B
Avg. vol.
286.84K
Volume
192.84K
52-wk high
$21.50
52-wk low
$11.89
EPS
-$0.44
Beta
2.21
Shares outstanding
130.13M
No. of employees
108
News stories
From web sources and news partners
The Motley Fool
·
1 hour ago
The S&P 500 Just Fell More Than 4% in a Day From Near Its Record. Here's What Happened Next in 2 Similar Situations Since 1950.
Reuters Connect
·
6 hours ago
A screen displays the Dow Jones Industrial Average after the closing bell on the floor of the NYSE in New York
qz.com
·
12 hours ago
Stock futures explained: how Dow, S&P 500 and Nasdaq-100 contracts work
StoneX
·
1 day ago
S&P 500 Forecast: SPX rebounds after strong NFP led by tech
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd
CEOSilviu Itescu
Employees108
Founded2004
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitemesoblast.com